High-Dose Flu Vaccine May Significantly Reduce Alzheimer’s Risk

Adults aged 65 and older who receive a high-dose influenza vaccine may have a significantly lower risk of developing Alzheimer’s disease compared to those who receive a standard-dose vaccine, according to a large observational study.

The research, published in the journal Neurology, found that the high-dose flu vaccine was associated with a nearly 55% reduced risk of Alzheimer’s disease in this age group over a period of roughly two years.

This finding builds upon previous research by the same team, which indicated that the standard-dose influenza vaccine was tied to a 40% reduced risk of developing the disease over a four-year period.

Study Methodology and Findings

The retrospective cohort study was led by researchers at the McGovern Medical School at UTHealth in Houston. The team analyzed health data from approximately 165,000 older adults who had been administered either a high-dose or a standard-dose influenza vaccine.

A key distinction between the two vaccines is the amount of antigen—the component responsible for generating an immune response. The high-dose influenza vaccine contains four times the antigen found in standard-dose versions.

The study also noted differences in how the vaccines affected different genders. While both men and women showed a lower risk of Alzheimer’s disease after receiving the high-dose vaccine compared to the standard dose, the protective effect appeared to be more consistent and lasted longer in women.

The Link Between Vaccination and Brain Health

Researchers are investigating the biological mechanisms that might link vaccination to a reduced risk of neurodegeneration. A leading hypothesis suggests that inoculation may strengthen the body’s immune defenses while simultaneously dampening inflammation.

Inflammation is believed to play a significant role in the development of Alzheimer’s disease. By reducing this inflammation, vaccines may potentially help protect the brain from the progression of the disease.

Paul Schulz, MD, a professor and neurologist at UTHealth Houston and the lead author of the study, noted that this research continues a line of inquiry including a 2022 study. That earlier work found that influenza vaccinations could help reduce the risk of Alzheimer’s disease by up to 40% with six annual vaccinations.

Broader Public Health Context

The Centers for Disease Control and Prevention recommends that all adults aged 65 years and older receive the high-dose influenza vaccine to better protect against the flu.

The relationship between vaccines and dementia risk is being explored across several different types of immunizations. Beyond the flu vaccine, other research suggests a potential link between reduced Alzheimer’s and dementia risk and the following:

• The pneumococcal vaccine used for pneumonia.
• The tetanus and diphtheria (Tdap/Td) vaccine.
• The shingles vaccine, which a December 2025 study suggested might help lower dementia risk and slow the progression of the disease.

While these observational findings indicate a strong correlation between high-dose vaccination and reduced Alzheimer’s risk, researchers continue to examine how immune system activity contributes to the prevention of dementia.